ATEA PHARMACEUTICALS
Atea Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of next-generation therapeutics for severe human viral infections. It caters to the healthcare industry and engages in the discovery and development of antiviral therapeutics that enable patients to have treatment for infections caused by RNA and DNA viruses. Atea Pharmaceuticals was established in 2014 and is headquartered in Boston, Massachusetts.
ATEA PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.ateapharma.com
Total Employee:
11+
Status:
Active
Total Funding:
283.43 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager WordPress Google Universal Analytics Global Site Tag Sitelinks Search Box Yoast WordPress SEO Plugin Yoast SEO Premium
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series D - Atea Pharmaceuticals
Sectoral Asset Management
Sectoral Asset Management investment in Series D - Atea Pharmaceuticals
Ally Bridge Group
Ally Bridge Group investment in Series D - Atea Pharmaceuticals
Redmile Group
Redmile Group investment in Series D - Atea Pharmaceuticals
Morningside Venture Investments
Morningside Venture Investments investment in Series D - Atea Pharmaceuticals
Perceptive Advisors
Perceptive Advisors investment in Series D - Atea Pharmaceuticals
Rock Springs Capital
Rock Springs Capital investment in Series D - Atea Pharmaceuticals
T. Rowe Price
T. Rowe Price investment in Series D - Atea Pharmaceuticals
Cormorant Asset Management
Cormorant Asset Management investment in Series D - Atea Pharmaceuticals
Solasta Ventures
Solasta Ventures investment in Series D - Atea Pharmaceuticals
Key Employee Changes
Date | New article |
---|---|
2022-02-10 | Atea Pharmaceuticals Appoints Nancy Gail Berry Agrawal, Ph.D., as Executive Vice President of Preclinical Development |
Official Site Inspections
http://www.ateapharma.com Semrush global rank: 3.79 M Semrush visits lastest month: 3.52 K
- Host name: 104.26.11.50
- IP address: 104.26.11.50
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago